Bayer&#39;s blood-clot drug beats Lovenox in key study
525921
Bayer AG&#39;s  experimental pill  rivaroxaban is significantly more effective than standard  injections of Lovenox in preventing blood clots after knee  surgery, researchers said on Sunday.
348152
The German drug maker Bayer said its third-quarter profit fell 35 percent on costs related to its acquisition of a rival, Schering, but its performance still exceeded analystsÂ expectations. Bayer earned 320 million euros ($419 million) in the three months through September, down from 493 million euros a year earlier. Sales rose 26 percent, to 7.78 billion euros ($10.2 billion). The company, based in Leverkusen, said it booked special charges totaling 139 million euros ($182 million) in the quarter, with 106 million euros ($139 million) of that mostly attributable to the integration of its health care unit with Schering. Bayer bought Schering in June in a deal worth nearly 16.9 billion euros ($22 billion) to strengthen its health care business. The company said its health care unit was Âthe principal growth engine for BayerÂs business in the third quarter,Â with sales climbing 73 percent, to 3.48 billion euros ($4.56 billion).
64799
Merck&#39;s (nyse: MRK - news - people ) decision is based on new three-year data from a clinical trial designed to test the effect of Vioxx on preventing colorectalpolyps.
573459
A key study of its lead drug proceeds faster than expected.
704534
Bayer HealthCare, a U.S.-based unit of Bayer AG  , stopped a late-stage trial of Nexavar in patients  with non-small cell lung cancer, after an independent data  monitoring committee concluded that the study would not meet  the main goal of improved overall survival.
236457
Roche Holding AG on Monday said new data  showed cancer drug MabThera significantly extended survival and  cured more patients with aggressive lymphoma than chemotherapy  alone.
453137
An experimental drug from Eli Lilly reduced heart attacks in patients with heart disease by 24 percent compared with the current standard treatment.
119762
The biotechnology company said Thursday that its experimental osteoporosis drug proved superior to Fosamax from Merck in a clinical trial.
538184
A study in a leading medical journal found Pfizer&#39;s Celebrex does not pose the same risk of causing heart attacks as Vioxx, the competing medicine Merck withdrew from the market because of safety concerns.
564001
A drug being developed by Bayer AG and Onyx Pharmaceuticals Inc. shrank tumors in some liver cancer patients and temporarily stabilized the
365325
Novartis AG&#39;s Prexige painkiller is  significantly better for blood pressure than older generic drug  ibuprofen, researchers said on Friday.
545405
An updated analysis of data from studies of anemia drugs used with cancer treatments showed that they increase risk of death and blood clots, an industry newsletter reported on Friday.
298048
Eli Lilly and Co.&#39;s Alimta lung cancer medicine was as effective as Sanofi-Aventis SA&#39;s Taxotere treatment while causing fewer serious side effects in patients with advanced lung tumors, according to a study.
304307
Pfizer Inc. on Friday said two small  clinical trials showed heart bypass surgery patients taking  Bextra, an anti-inflammatory in the same class as the recently  withdrawn drug Vioxx, had a higher risk of stroke and heart  attack.
584007
Investors reward the drugmaker for positive study results.
730064
ImClone Systems Inc. and Bristol-Myers Squibb Co. claimed Tuesday that the drug Erbitux improved the survival rate of patients with the most common type of lung cancer in a late-stage study. ImClone shares jumped 21 percent.
209656
Bayer AG, Germany s second-biggest drug and chemical maker, had a third consecutive quarterly profit and boosted its sales and earnings targets as demand grew for plastics and chemicals.